Ben Sharvy

Long/short equity, contrarian, deep value
Ben Sharvy
Long/short equity, contrarian, deep value
Contributor since: 2008
Retrophin Needs Some Retro Pricing
Cellceutix Overvalued By 90-99%
Infinity Energy Resources Looks Like A Zero
Implant Sciences: Diluted And Deluded
Trading Closed-End Funds - An Update
A System for Trading Closed-End Funds